ALEXANDRA SCHMERGE: Open Payments
NPI 1679299911 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,829 in 194 payments from 21 companies in 2025. Trend: 2023 $1,956 · 2024 $2,338 · 2025 $7,829
Food & beverage: $3,283Travel & lodging: $2,565Consulting: $1,800Education: $180
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 21 | $4,968 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 27 | $501 |
| ABBVIE INC. | 38 | $399 |
| Galderma Laboratories, L.P. | 19 | $330 |
| Amgen Inc. | 8 | $249 |
| Regeneron Healthcare Solutions, Inc. | 19 | $243 |
| Janssen Biotech, Inc. | 12 | $240 |
| UCB, Inc. | 10 | $163 |
| Novartis Pharmaceuticals Corporation | 7 | $141 |
| GENZYME CORPORATION | 10 | $139 |
Products named: Zoryve, DUPIXENT, NEMLUVIO, OTEZLA, ILUMYA, TREMFYA, RINVOQ, Winlevi.
Industry payments across IN — which companies pay providers there.
